Ran Jin1, Sophia Banton2, ViLinh T Tran2, Juna V Konomi1, Shuzhao Li2, Dean P Jones2, Miriam B Vos3. 1. Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA. 2. Division of Pulmonary, Allergy and Critical Care Medicine, School of Medicine, Emory University, Atlanta, GA. 3. Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA. Electronic address: mvos@emory.edu.
Abstract
OBJECTIVE: To conduct an untargeted, high resolution exploration of metabolic pathways that was altered in association with hepatic steatosis in adolescents. STUDY DESIGN: This prospective, case-control study included 39 Hispanic-American, obese adolescents aged 11-17 years evaluated for hepatic steatosis using magnetic resonance spectroscopy. Of these 39 individuals, 30 had hepatic steatosis ≥5% and 9 were matched controls with hepatic steatosis <5%. Fasting plasma samples were analyzed in triplicate using ultra-high resolution metabolomics on a Thermo Fisher Q Exactive mass spectrometry system, coupled with C18 reverse phase liquid chromatography. Differences in plasma metabolites between adolescents with and without nonalcoholic fatty liver disease (NAFLD) were determined by independent t tests and visualized using Manhattan plots. Untargeted pathway analyses using Mummichog were performed among the significant metabolites to identify pathways that were most dysregulated in NAFLD. RESULTS: The metabolomics analysis yielded 9583 metabolites, and 7711 with 80% presence across all samples remained for statistical testing. Of these, 478 metabolites were associated with the presence of NAFLD compared with the matched controls. Pathway analysis revealed that along with lipid metabolism, several major amino acid pathways were dysregulated in NAFLD, with tyrosine metabolism being the most affected. CONCLUSIONS: Metabolic pathways of several amino acids are significantly disturbed in adolescents with elevated hepatic steatosis. This is a novel finding and suggests that these pathways may be integral in the mechanisms of NAFLD.
OBJECTIVE: To conduct an untargeted, high resolution exploration of metabolic pathways that was altered in association with hepatic steatosis in adolescents. STUDY DESIGN: This prospective, case-control study included 39 Hispanic-American, obese adolescents aged 11-17 years evaluated for hepatic steatosis using magnetic resonance spectroscopy. Of these 39 individuals, 30 had hepatic steatosis ≥5% and 9 were matched controls with hepatic steatosis <5%. Fasting plasma samples were analyzed in triplicate using ultra-high resolution metabolomics on a Thermo Fisher Q Exactive mass spectrometry system, coupled with C18 reverse phase liquid chromatography. Differences in plasma metabolites between adolescents with and without nonalcoholic fatty liver disease (NAFLD) were determined by independent t tests and visualized using Manhattan plots. Untargeted pathway analyses using Mummichog were performed among the significant metabolites to identify pathways that were most dysregulated in NAFLD. RESULTS: The metabolomics analysis yielded 9583 metabolites, and 7711 with 80% presence across all samples remained for statistical testing. Of these, 478 metabolites were associated with the presence of NAFLD compared with the matched controls. Pathway analysis revealed that along with lipid metabolism, several major amino acid pathways were dysregulated in NAFLD, with tyrosine metabolism being the most affected. CONCLUSIONS: Metabolic pathways of several amino acids are significantly disturbed in adolescents with elevated hepatic steatosis. This is a novel finding and suggests that these pathways may be integral in the mechanisms of NAFLD.
Authors: Xiaojiao Zheng; Guoxiang Xie; Aihua Zhao; Linjing Zhao; Chun Yao; Norman H L Chiu; Zhanxiang Zhou; Yuqian Bao; Weiping Jia; Jeremy K Nicholson; Wei Jia Journal: J Proteome Res Date: 2011-10-24 Impact factor: 4.466
Authors: Sulin Cheng; Petri Wiklund; Reija Autio; Ronald Borra; Xiaowei Ojanen; Leiting Xu; Timo Törmäkangas; Markku Alen Journal: PLoS One Date: 2015-10-06 Impact factor: 3.240
Authors: Peter Würtz; Mika Tiainen; Ville-Petteri Mäkinen; Antti J Kangas; Pasi Soininen; Juha Saltevo; Sirkka Keinänen-Kiukaanniemi; Pekka Mäntyselkä; Terho Lehtimäki; Markku Laakso; Antti Jula; Mika Kähönen; Mauno Vanhala; Mika Ala-Korpela Journal: Diabetes Care Date: 2012-05-04 Impact factor: 19.112
Authors: Peter Würtz; Pasi Soininen; Antti J Kangas; Tapani Rönnemaa; Terho Lehtimäki; Mika Kähönen; Jorma S Viikari; Olli T Raitakari; Mika Ala-Korpela Journal: Diabetes Care Date: 2012-11-05 Impact factor: 19.112
Authors: Sonia Michail; Malinda Lin; Mark R Frey; Rob Fanter; Oleg Paliy; Brian Hilbush; Nicholas V Reo Journal: FEMS Microbiol Ecol Date: 2014-12-05 Impact factor: 4.519
Authors: Mario Arciello; Manuele Gori; Roberta Maggio; Barbara Barbaro; Mirko Tarocchi; Andrea Galli; Clara Balsano Journal: Int J Mol Sci Date: 2013-11-07 Impact factor: 5.923
Authors: Cyrielle Caussy; Veeral H Ajmera; Puneet Puri; Cynthia Li-Shin Hsu; Shirin Bassirian; Mania Mgdsyan; Seema Singh; Claire Faulkner; Mark A Valasek; Emily Rizo; Lisa Richards; David A Brenner; Claude B Sirlin; Arun J Sanyal; Rohit Loomba Journal: Gut Date: 2018-12-19 Impact factor: 23.059
Authors: Wei Perng; Ellen C Francis; Harry A Smith; John Carey; Dongqing Wang; Katerina M Kechris; Dana Dabelea Journal: J Clin Endocrinol Metab Date: 2020-09-01 Impact factor: 5.958
Authors: Luiz Gustavo Gardinassi; Regina Joice Cordy; Marcus V G Lacerda; Jorge L Salinas; Wuelton M Monteiro; Gisely C Melo; André M Siqueira; Fernando F Val; ViLinh Tran; Dean P Jones; Mary R Galinski; Shuzhao Li Journal: Int J Med Microbiol Date: 2017-09-06 Impact factor: 3.473
Authors: Ran Jin; Rob McConnell; Cioffi Catherine; Shujing Xu; Douglas I Walker; Nikos Stratakis; Dean P Jones; Gary W Miller; Cheng Peng; David V Conti; Miriam B Vos; Leda Chatzi Journal: Environ Int Date: 2019-11-16 Impact factor: 13.352
Authors: Nikos Stratakis; David V Conti; Ran Jin; Katerina Margetaki; Damaskini Valvi; Alexandros P Siskos; Léa Maitre; Erika Garcia; Nerea Varo; Yinqi Zhao; Theano Roumeliotaki; Marina Vafeiadi; Jose Urquiza; Silvia Fernández-Barrés; Barbara Heude; Xavier Basagana; Maribel Casas; Serena Fossati; Regina Gražulevičienė; Sandra Andrušaitytė; Karan Uppal; Rosemary R C McEachan; Eleni Papadopoulou; Oliver Robinson; Line Småstuen Haug; John Wright; Miriam B Vos; Hector C Keun; Martine Vrijheid; Kiros T Berhane; Rob McConnell; Lida Chatzi Journal: Hepatology Date: 2020-10-19 Impact factor: 17.425